Posts Tagged ‘Tysabri’
RTP Wrapup 10/30
Friday, October 30, 2009, 4:24 am No Comments | Post a CommentA test that assesses Tysabri’s risk of causing potentially deadly side effects could boost demand of the multiple sclerosis drug, GlaxoSmithKline is not ready to talk about efforts to develop a successor to best selling asthma medicine Advair and RTI International researchers will try to make biomass “oil.”
RTP Wrapup 10/23
Thursday, October 22, 2009, 5:43 pm No Comments | Post a CommentWorries of Tysabri’s side effect risks are on the rise, BDSI goes on a publicity blitz to boost its stock and Trimeris finds a potential buyer.
